CELG
Transfer...
 Symbol:



NASDAQ / Sector: Healthcare / Sub-Sector: Biotechnology / Stock Type: Speculative Growth
# of Employee: 6,971 / Fiscal Year End: 2016-12-31 / Stock Type: Large Growth
USD / Exchange Rate: 1 at 2016-11-22 / Estimation: $Confidential / / $

Celgene Corp is a biopharmaceutical company. It is engaged in the discovery, development and commercialization of therapies designed to treat cancer and immune-inflammatory related diseases.

Competitors | AnnualReport

Competitors List | Key Matrix Details

AMGN | NVO | GILD | BIIB | SHPG | VRTX | REGN | ALXN | GRFS | INCY | NKTR | CLRB |

Finance Highlights

Key Ratio Highlights | Key Ratio H | Income H | Balance H | Cash H | Income D | Balance D | Cash D | Top

{##FinanceKeyRatioHighlights}

Key Ratio Trend

{##FinanceKeyRatioTrend}

Income Statement Highlights | Key Ratio H | Income H | Balance H | Cash H | Income D | Balance D | Cash D | Top

ReportDatePeriodTypeRevenueCostInterestExContinuousNetIncomeDilutedShaProfitMargContinuousNetMargin
2014-06-25Quarter1,872,700k98,900k41,600k597,800k597,800k831,000,k94.70%31.90%31.90%
2014-09-25Quarter1,982,200k97,700k53,500k508,500k508,500k832,800,k95.10%25.70%25.70%
2014-12-25Quarter2,085,500k103,200k51,700k613,900k613,900k834,800,k95.10%29.40%29.40%
2015-03-25Quarter2,080,800k104m49,200k718,900k718,900k834,100,k95.00%34.50%34.50%
2015-06-25Quarter2,277,800k100,800k48,300k356,200k356,200k825,300,k95.60%15.60%15.60%
2015-09-25Quarter2,334,100k109,900k88,500k-34,100k-34,100k791,100,k95.30%-1.50%-1.50%
2015-12-25Quarter2,563,300k105,400k124,600k561m561m816,500,k95.90%21.90%21.90%
2016-03-25Quarter2,511,600k105,900k121,900k800,700k800,700k807,700,k95.80%31.90%31.90%
2016-06-25Quarter2,754,300k110,900k123,300k598,200k598,200k801,500,k96.00%21.70%21.70%
2016-09-25Quarter2,982,800k107,700k127,800k171,400k171,400k801,500,k96.40%5.70%5.70%
2016-12-25Quarter2,980,500k113,500k127,100k428,900k428,900k802,100,k96.20%14.40%14.40%
2017-03-25Quarter2,960m113m127m941m941m811,200,k96.20%31.80%31.80%
2017-06-25Quarter3,268m111m126m1,061m1,061m811,700,k96.60%32.50%32.50%
2017-09-25Quarter3,287m118m127m988m988m815,200,k96.40%30.10%30.10%
2017-12-25Quarter3,483m119m142m-81m-81m797,000,k96.60%-2.30%-2.30%
2018-03-25Quarter3,538m135m166m846m846m768,300,k96.20%23.90%23.90%
2018-06-25Quarter3,814m126m192m1,045m1,045m732,600,k96.70%27.40%27.40%
2018-09-25Quarter3,892m157m193m1,082m1,082m719,700,k96.00%27.80%27.80%
2018-12-25Quarter4,037m169m190m1,073m1,073m714,000,k95.80%26.60%26.60%
2019-03-25Quarter4,025m140m192m1,545m1,545m720,500,k96.50%38.40%38.40%
2019-06-25Quarter4,400m151m192m1,571m1,571m726,700,k96.60%35.70%35.70%

Income Statement Trend

ReportDatePeriodTypeRevenueCostInterestExContinuousNetIncomeDilutedShaProfitMargContinuousNetMargin
2015-06-25Quarter21.63%1.92%16.11%-40.41%-40.41%-0.69%0.95%-51.10%-51.10%
2015-09-25Quarter17.75%12.49%65.42%-106.71%-106.71%-5.01%0.21%-105.84%-105.84%
2015-12-25Quarter22.91%2.13%141.01%-8.62%-8.62%-2.19%0.84%-25.51%-25.51%
2016-03-25Quarter20.70%1.83%147.76%11.38%11.38%-3.17%0.84%-7.54%-7.54%
2016-06-25Quarter20.92%10.02%155.28%67.94%67.94%-2.88%0.42%39.10%39.10%
2016-09-25Quarter27.79%-2.00%44.41%-602.64%-602.64%1.31%1.15%-480.00%-480.00%
2016-12-25Quarter16.28%7.69%2.01%-23.55%-23.55%-1.76%0.31%-34.25%-34.25%
2017-03-25Quarter17.85%6.70%4.18%17.52%17.52%0.43%0.42%-0.31%-0.31%
2017-06-25Quarter18.65%0.09%2.19%77.37%77.37%1.27%0.63%49.77%49.77%
2017-09-25Quarter10.20%9.56%-0.63%476.43%476.43%1.71%0.00%428.07%428.07%
2017-12-25Quarter16.86%4.85%11.72%-118.89%-118.89%-0.64%0.42%-115.97%-115.97%
2018-03-25Quarter19.53%19.47%30.71%-10.10%-10.10%-5.29%0.00%-24.84%-24.84%
2018-06-25Quarter16.71%13.51%52.38%-1.51%-1.51%-9.74%0.10%-15.69%-15.69%
2018-09-25Quarter18.41%33.05%51.97%9.51%9.51%-11.71%-0.41%-7.64%-7.64%
2018-12-25Quarter15.91%42.02%33.80%-1,424.69%-1,424.69%-10.41%-0.83%-1,256.52%-1,256.52%
2019-03-25Quarter13.76%3.70%15.66%82.62%82.62%-6.22%0.31%60.67%60.67%
2019-06-25Quarter15.36%19.84%0.00%50.33%50.33%-0.81%-0.10%30.29%30.29%


Balance Sheet Highlights | Key Ratio H | Income H | Balance H | Cash H | Income D | Balance D | Cash D | Top

ReportDatePeriodTypeEquityTotalAssetTotalLiabiCurrentAssCurrentLiaNonCurrentDebtEquityCurrentRat
2016-12-25Quarter6,599,300k28,085,600k21,486,300k10,867,500k2,959,200k18,527,100k.307.272
2017-03-25Quarter7,644m28,820m21,176m11,617m2,629m18,547m.361.226
2017-06-25Quarter8,445m30,306m21,861m13,136m3,240m18,621m.386.247
2017-09-25Quarter9,850m31,736m21,886m14,783m4,049m17,837m.450.274
2017-12-25Quarter6,921m30,141m23,220m14,892m2,987m20,233m.298.201
2018-03-25Quarter5,172m34,556m29,384m7,872m3,115m26,269m.176.396
2018-06-25Quarter3,430m33,444m30,014m6,853m4,502m25,512m.114.657
2018-09-25Quarter4,860m34,215m29,355m7,827m3,683m25,672m.166.471
2018-12-25Quarter6,161m35,480m29,319m9,067m4,057m25,262m.210.447
2019-03-25Quarter8,165m37,639m29,474m10,981m3,955m25,519m.277.360
2019-06-25Quarter280m0.00.029,132m0.0327m∞.000

Balance Sheet Trend

ReportDatePeriodTypeEquityTotalAssetTotalLiabiCurrentAssCurrentLiaNonCurrentDebtEquityCurrentRat
2017-12-25Quarter4.87%7.32%8.07%37.03%0.94%9.21%-2.93%-26.10%
2018-03-25Quarter-32.34%19.90%38.76%-32.24%18.49%41.63%-51.25%75.22%
2018-06-25Quarter-59.38%10.35%37.29%-47.83%38.95%37.01%-70.47%165.99%
2018-09-25Quarter-50.66%7.81%34.13%-47.05%-9.04%43.93%-63.11%71.90%
2018-12-25Quarter-10.98%17.71%26.27%-39.11%35.82%24.86%-29.53%122.39%
2019-03-25Quarter57.87%8.92%0.31%39.49%26.97%-2.86%57.39%-9.09%
2019-06-25Quarter-91.84%-100.00%-100.00%325.10%-100.00%-98.72%-100.00%-100.00%


Cash Flow Highlights | Key Ratio H | Income H | Balance H | Cash H | Income D | Balance D | Cash D | Top

{##CashFlowHighlights}

Cash Flow Trend

{##CashFlowTrend}


Finance Detail

Income Statement Details | Key Ratio H | Income H | Balance H | Cash H | Income D | Balance D | Cash D | Top



Balance Sheet Details | Key Ratio H | Income H | Balance H | Cash H | Income D | Balance D | Cash D | Top



Cash Flow Details | Key Ratio H | Income H | Balance H | Cash H | Income D | Balance D | Cash D | Top




Note